ice...I have always respected your opinions but must say this one appears off base. The BOD hasn't officially received authorization to consider an R/S, let alone execute an acquisition based on post split shares.
Besides, as Elmer has pointed out, using post split as the basis makes even less sense.
Do consider that the newspaper is already reporting that the value of the deal was $257,000. If Trace accepted an option at $0.02, they must feel there is reason to expect that the S/P will again see that level or higher. Of course, by the time it reaches $0.02, the original sale will be worth closer to $500,000, and so on and so forth...$250,000 for every penny rise in S/P.
Perhaps the folks at Trace, like many long shareholders, threw their lot in with DNAPrint with a view to the future value. In that sense, it could be either the smartest...or the dumbest...thing they've ever done...lol
JMHO,
W2P